Health Care [ 9/12 ] | Biotechnology [ 61/74 ]
NASDAQ | Common Stock
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.
The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy.
In addition, it is developing AAV-based gene therapy through its AIM vector platform programs.
The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015.
Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 17, 25 | -0.32 Increased by +58.97% | -0.34 Increased by +7.98% |
| Nov 11, 24 | -0.31 Increased by +34.52% | -0.40 Increased by +21.43% |
| Aug 12, 24 | 0.19 Increased by +120.65% | -0.36 Increased by +152.78% |
| May 15, 24 | -1.16 Decreased by -114.81% | -0.51 Decreased by -127.45% |
| Mar 18, 24 | -0.77 Decreased by -150.33% | -0.47 Decreased by -63.83% |
| Nov 13, 23 | -0.48 Increased by +67.57% | -0.53 Increased by +9.43% |
| Aug 8, 23 | -0.92 Increased by +55.77% | -0.68 Decreased by -35.29% |
| Apr 14, 23 | -0.54 Increased by +84.57% | -0.58 Increased by +6.90% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 0.00 Decreased by -100.00% | -9.29 M Increased by +43.99% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -30.27 M Decreased by -155.74% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by -100.00% | 7.41 M Increased by +144.47% | Increased by +N/A% Increased by +N/A% |
| Mar 31, 24 | 0.00 Decreased by -100.00% | -31.58 M Decreased by -246.74% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 2.82 M Increased by +4.05 K% | -16.59 M Decreased by -358.63% | Decreased by -587.50% Decreased by -106.23% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -11.84 M Decreased by -24.80% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 3.50 M Increased by +250.00% | -16.65 M Decreased by -133.84% | Decreased by -475.83% Increased by +33.19% |
| Mar 31, 23 | 68.00 K Decreased by -80.35% | -9.11 M Increased by +56.61% | Decreased by -13.39 K% Decreased by -120.75% |